| Alina H Tobey, DO | |
|
1691 Innovation Dr Ste 2100, Blacksburg, VA 24060-6828 | |
| (540) 232-8405 | |
| Not Available |
| Full Name | Alina H Tobey |
|---|---|
| Gender | Female |
| Speciality | Osteopathic Manipulative Medicine |
| Experience | 19 Years |
| Location | 1691 Innovation Dr Ste 2100, Blacksburg, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033232269 | NPI | - | NPPES |
| 378129 | Other | VA | ANTHEM |
| 0009717397 | Other | VA | AETNA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lewisgale Hospital Montgomery | Blacksburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Academic Primary Care Associates | 3678571866 | 8 |
News Archive
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
Sunshine State Health Plan announced today that it has received approval from the Florida Office of Insurance Regulation and the Centers for Medicare and Medicaid Services to participate as a Qualified Health Plan in the Florida Health Insurance Marketplace in three South Florida counties, where it will offer a line of products branded as Ambetter from Sunshine Health.
The University of Minnesota's Clinical and Translational Science Institute received more than $42 million in renewed National Institutes of Health funding through the National Center for Advancing Translational Sciences' Clinical and Translational Science Award program.
The word 'synbiotic' appears on a growing number of food and supplement products, with synbiotic ingredients showing promise for modulating the community of microbes living in the human gut, while providing a health benefit.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.
› Verified 8 days ago
| Entity Name | Academic Primary Care Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053340281 PECOS PAC ID: 3678571866 Enrollment ID: O20061122000420 |
News Archive
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
Sunshine State Health Plan announced today that it has received approval from the Florida Office of Insurance Regulation and the Centers for Medicare and Medicaid Services to participate as a Qualified Health Plan in the Florida Health Insurance Marketplace in three South Florida counties, where it will offer a line of products branded as Ambetter from Sunshine Health.
The University of Minnesota's Clinical and Translational Science Institute received more than $42 million in renewed National Institutes of Health funding through the National Center for Advancing Translational Sciences' Clinical and Translational Science Award program.
The word 'synbiotic' appears on a growing number of food and supplement products, with synbiotic ingredients showing promise for modulating the community of microbes living in the human gut, while providing a health benefit.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alina H Tobey, DO 1691 Innovation Dr, Ste 2100, Blacksburg, VA 24060-6618 Ph: (540) 443-7180 | Alina H Tobey, DO 1691 Innovation Dr Ste 2100, Blacksburg, VA 24060-6828 Ph: (540) 232-8405 |
News Archive
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
Sunshine State Health Plan announced today that it has received approval from the Florida Office of Insurance Regulation and the Centers for Medicare and Medicaid Services to participate as a Qualified Health Plan in the Florida Health Insurance Marketplace in three South Florida counties, where it will offer a line of products branded as Ambetter from Sunshine Health.
The University of Minnesota's Clinical and Translational Science Institute received more than $42 million in renewed National Institutes of Health funding through the National Center for Advancing Translational Sciences' Clinical and Translational Science Award program.
The word 'synbiotic' appears on a growing number of food and supplement products, with synbiotic ingredients showing promise for modulating the community of microbes living in the human gut, while providing a health benefit.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.
› Verified 8 days ago